CAC 40
7 675,62 -20,16 (-0,26 %) Euro Stoxx 50
4 979,39 -8,09 (-0,16 %) Dow Jones
39 254,63 -53,37 (-0,14 %) EUR/USD
1,0826 +0,0012 (+0,11 %) Gold future
2 394,50 +25,10 (+1,06 %) Bitcoin EUR
52 139,96 -1 566,79 (-2,92 %)
Perrigo Company plc (PIG.F)
Perrigo Company plc
The Sharp Building
Hogan Place
Dublin D02 TY74
Ireland
353 1 709 4000
https://www.perrigo.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein: 9 140
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Mr. Patrick Lockwood-Taylor | President, CEO & Director | 2,2M | S.O. | S.O. |
| Mr. Eduardo Guarita Bezerra | Executive VP & CFO | 1,11M | S.O. | 1976 |
| Mr. Ronald C. Janish | Chief Transformation Officer and Executive VP of Global Operations & Supply Chain | 1,26M | S.O. | 1966 |
| Mr. Svend Andersen | Executive VP & President of Consumer Self-Care International | 1,03M | S.O. | 1962 |
| Ms. Kyle L. Hanson | Special Counsel to the CEO and the Board & Interim General Counsel for Strategic Litigation | 874,77k | S.O. | 1965 |
| Mr. Shannon Hukill | Senior Director of Technical Operations | S.O. | S.O. | S.O. |
| Ms. Alison Ives | Executive VP & Chief Scientific Officer | S.O. | S.O. | 1981 |
| Mr. Bradley Joseph | Vice President of Global Investor Relations & Corporate Communications | S.O. | S.O. | S.O. |
| Mr. Todd W. Kingma | Interim EVP, General Counsel & Corporate Secretary | 1,19M | S.O. | 1960 |
| Ms. Mary Reilly-Brest | Director of Global Organizational and Human Resource Development | S.O. | S.O. | S.O. |
Description
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Perrigo Company plc en date du 1 juillet 2024 est 1. Les scores principaux sont Audit : 5; Société : 1; Droits des actionnaires : 1; Compensation : 3.
